These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 1377473)

  • 21. NK-associated receptors on CD8 T cells from treatment-naive HIV-infected individuals: defective expression of CD56.
    Tarazona R; DelaRosa O; Casado JG; Torre-Cisneros J; Villanueva JL; Galiani MD; Peña J; Solana R
    AIDS; 2002 Jan; 16(2):197-200. PubMed ID: 11807303
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Structural properties of the glycoplasmanylinositol anchor phospholipid of the complement membrane attack complex inhibitor CD59.
    Ratnoff WD; Knez JJ; Prince GM; Okada H; Lachmann PJ; Medof ME
    Clin Exp Immunol; 1992 Mar; 87(3):415-21. PubMed ID: 1371955
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Increased numbers of primed activated CD8+CD38+CD45RO+ T cells predict the decline of CD4+ T cells in HIV-1-infected patients.
    Bofill M; Mocroft A; Lipman M; Medina E; Borthwick NJ; Sabin CA; Timms A; Winter M; Baptista L; Johnson MA; Lee CA; Phillips AN; Janossy G
    AIDS; 1996 Jul; 10(8):827-34. PubMed ID: 8828739
    [TBL] [Abstract][Full Text] [Related]  

  • 24. CD59, an LY-6-like protein expressed in human lymphoid cells, regulates the action of the complement membrane attack complex on homologous cells.
    Davies A; Simmons DL; Hale G; Harrison RA; Tighe H; Lachmann PJ; Waldmann H
    J Exp Med; 1989 Sep; 170(3):637-54. PubMed ID: 2475570
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Anergy and apoptosis in CD8+ T cells from HIV-infected persons.
    Lewis DE; Tang DS; Adu-Oppong A; Schober W; Rodgers JR
    J Immunol; 1994 Jul; 153(1):412-20. PubMed ID: 7515928
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Increased proliferation within T lymphocyte subsets of HIV-infected adolescents.
    Starr SE; Sarr M; Campbell DE; Wilson CM; Douglas SD
    AIDS Res Hum Retroviruses; 2002 Nov; 18(17):1301-10. PubMed ID: 12487818
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The CD59 antigen--a multifunctional molecule.
    Walsh LA; Tone M; Thiru S; Waldmann H
    Tissue Antigens; 1992 Nov; 40(5):213-20. PubMed ID: 1282740
    [No Abstract]   [Full Text] [Related]  

  • 28. Complement control proteins, CD46, CD55, and CD59, as common surface constituents of human and simian immunodeficiency viruses and possible targets for vaccine protection.
    Montefiori DC; Cornell RJ; Zhou JY; Zhou JT; Hirsch VM; Johnson PR
    Virology; 1994 Nov; 205(1):82-92. PubMed ID: 7526538
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Phenotypic analysis of complement receptor 2+ T lymphocytes: reduced expression on CD4+ cells in HIV-infected persons.
    June RA; Landay AL; Stefanik K; Lint TF; Spear GT
    Immunology; 1992 Jan; 75(1):59-65. PubMed ID: 1371493
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Impact of antiretroviral and tuberculosis therapies on CD4
    Chiacchio T; Petruccioli E; Vanini V; Cuzzi G; La Manna MP; Orlando V; Pinnetti C; Sampaolesi A; Antinori A; Caccamo N; Goletti D
    Immunol Lett; 2018 Jun; 198():33-43. PubMed ID: 29635002
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immunological benefits of antiretroviral therapy in very early stages of asymptomatic chronic HIV-1 infection.
    Plana M; García F; Gallart T; Tortajada C; Soriano A; Palou E; Maleno MJ; Barceló JJ; Vidal C; Cruceta A; Miró JM; Gatell JM
    AIDS; 2000 Sep; 14(13):1921-33. PubMed ID: 10997396
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Decay-accelerating factor and CD59 expression in peripheral blood cells in aplastic anaemia and report of a case of paroxysmal nocturnal haemoglobinuria secondary to aplastic anaemia.
    Fujioka S; Yamada T
    Br J Haematol; 1993 Apr; 83(4):660-2. PubMed ID: 7686037
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Changes in viral expression and cytokine profile induced by a polyantigenic immunomodulator in HIV-infected peripheral blood mononuclear cells.
    Ríos Z; Ríos EO; Garcia MI; De Leon C; Guzman LM; Rodriguez W; Romero D; Hunter R
    Cell Mol Biol (Noisy-le-grand); 1995; 41 Suppl 1():S93-101. PubMed ID: 8574153
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The influence of tumour necrosis factor-alpha, interleukin-1 beta and interferon-gamma on the expression and function of the complement regulatory protein CD59 on the human colonic adenocarcinoma cell line HT29.
    Bjørge L; Jensen TS; Ulvestad E; Vedeler CA; Matre R
    Scand J Immunol; 1995 Apr; 41(4):350-6. PubMed ID: 7534941
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Increased expression of CD80, CD86 and CD70 on T cells from HIV-infected individuals upon activation in vitro: regulation by CD4+ T cells.
    Wolthers KC; Otto SA; Lens SM; Kolbach DN; van Lier RA; Miedema F; Meyaard L
    Eur J Immunol; 1996 Aug; 26(8):1700-6. PubMed ID: 8765009
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of activation marker and TCR V beta gene product expression by CD4+ and CD8+ T cells in peripheral blood and lymph nodes from HIV-infected patients.
    Ramzaoui S; Jouen-Beades F; Michot F; Borsa-Lebas F; Humbert G; Tron F
    Clin Exp Immunol; 1995 Feb; 99(2):182-8. PubMed ID: 7851009
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Defective killing activity against gp120/41-expressing human erythroleukaemic K562 cell line by monocytes and natural killer cells from HIV-infected individuals.
    Ahmad A; Menezes J
    AIDS; 1996 Feb; 10(2):143-9. PubMed ID: 8838701
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Human lung cancer cell lines express cell membrane complement inhibitory proteins and are extremely resistant to complement-mediated lysis; a comparison with normal human respiratory epithelium in vitro, and an insight into mechanism(s) of resistance.
    Varsano S; Rashkovsky L; Shapiro H; Ophir D; Mark-Bentankur T
    Clin Exp Immunol; 1998 Aug; 113(2):173-82. PubMed ID: 9717965
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Expression of CD59, a complement regulator protein and a second ligand of the CD2 molecule, and CD46 in normal and neoplastic colorectal epithelium.
    Koretz K; Brüderlein S; Henne C; Möller P
    Br J Cancer; 1993 Nov; 68(5):926-31. PubMed ID: 7692919
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Regulation of CD59 expression on the human endothelial cell line EA.hy 926.
    Meri S; Mattila P; Renkonen R
    Eur J Immunol; 1993 Oct; 23(10):2511-6. PubMed ID: 7691609
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.